Key Laboratory of Radiobiology (Ministry of Health), School of Public Health, Jilin University, Changchun, China.
Cancer Treat Rev. 2010 Apr;36(2):157-63. doi: 10.1016/j.ctrv.2009.11.008. Epub 2009 Dec 23.
Hepatocellular carcinoma (HCC), the 5th most common cancer and the third most common cause of cancer-related death in the world with an estimated incidence of approximately 1 million new cases annually, has becoming a major global health problem in the world. A variety of treatment modalities, including resection, liver transplantation, transarterial chemoembolization (TACE), local ablative therapy and radiation therapy (RT) have been reported. Although partial hepatectomy and liver transplantation may offer the best chance of cure, only 15% of the patients have the chance to be treated by surgery when diagnosed. The effectiveness of systemic chemotherapy for HCC has been minimal, and local ablative therapy may offer comparable survival in patients with small HCC and preserve liver function. Recently, with developments in radiotherapy techniques, radiotherapy has been shown to play potential roles in a wide spectrum of HCC and to become more important so that it is necessary to evaluate the effect of radiotherapy in treatment of HCC. This paper is aiming mainly at the current radiation therapy strategies and their current advances, the optimal radiation therapy strategies will complement the current treatments and improve the treatment efficiency.
肝细胞癌(HCC)是全球第 5 大常见癌症,也是第 3 大癌症相关死亡原因,全球每年估计有近 100 万例新发病例,已成为全球主要的健康问题。目前已有多种治疗方法,包括手术切除、肝移植、经动脉化疗栓塞(TACE)、局部消融治疗和放射治疗(RT)等。尽管部分肝切除术和肝移植可能提供最好的治愈机会,但只有 15%的患者在确诊时可以接受手术治疗。HCC 的全身化疗效果甚微,而局部消融治疗可能为小 HCC 患者提供相似的生存机会并保留肝功能。最近,随着放射治疗技术的发展,放射治疗已被证明在广泛的 HCC 中有潜在作用,并变得更加重要,因此有必要评估放疗在 HCC 治疗中的作用。本文主要针对目前的放射治疗策略及其进展,最佳的放射治疗策略将补充现有的治疗方法,提高治疗效率。
Cancer Treat Rev. 2009-12-23
Hepatobiliary Pancreat Dis Int. 2008-6
Cancer Radiother. 2008-3
Ann Ital Chir. 2008
Hepatogastroenterology. 2007-9
Naunyn Schmiedebergs Arch Pharmacol. 2025-5-7
Cell Death Dis. 2024-1-10
J Clin Transl Hepatol. 2018-3-28